Simplex Trading’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-5,000
| Closed | -$107K | – | 9474 |
|
|
2026
Q1 | $107K | Buy |
+5,000
| New | +$70.5K | ﹤0.01% | 5000 |
|
|
2025
Q4 | – | Sell |
-43,700
| Closed | -$308K | – | 8846 |
|
|
2025
Q3 | $308K | Buy |
43,700
+35,100
| +408% | +$242K | ﹤0.01% | 4420 |
|
|
2025
Q2 | $55K | Sell |
8,600
-5,600
| -39% | -$38.5K | ﹤0.01% | 5824 |
|
|
2025
Q1 | $112K | Sell |
14,200
-4,300
| -23% | -$46.3K | ﹤0.01% | 4944 |
|
|
2024
Q4 | $234K | Buy |
18,500
+15,300
| +478% | +$213K | ﹤0.01% | 4355 |
|
|
2024
Q3 | $44K | Sell |
3,200
-7,500
| -70% | -$107K | ﹤0.01% | 5995 |
|
|
2024
Q2 | $147K | Sell |
10,700
-1,800
| -14% | -$26.3K | ﹤0.01% | 4952 |
|
|
2024
Q1 | $206K | Sell |
12,500
-500
| -4% | -$7.48K | ﹤0.01% | 4820 |
|
|
2023
Q4 | $189K | Sell |
13,000
-500
| -4% | -$6.06K | ﹤0.01% | 4738 |
|
|
2023
Q3 | $165K | Buy |
13,500
+2,700
| +25% | +$35.2K | ﹤0.01% | 4553 |
|
|
2023
Q2 | $128K | Buy |
10,800
+8,000
| +286% | +$104K | ﹤0.01% | 4789 |
|
|
2023
Q1 | $37K | Buy |
2,800
+1,500
| +115% | +$29.3K | ﹤0.01% | 6253 |
|
|
2022
Q4 | $27K | Sell |
1,300
-1,300
| -50% | -$26.7K | ﹤0.01% | 6577 |
|
|
2022
Q3 | $52K | Sell |
2,600
-45,900
| -95% | -$976K | ﹤0.01% | 6395 |
|
|
2022
Q2 | $868K | Buy |
+48,500
| New | +$501K | ﹤0.01% | 2785 |
|
Other funds holding DAWN
Simplex Trading's DAWN Position: Q2 2026 in Review
Simplex Trading sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 64,464 shares — an estimated $1.38M sold.
Simplex Trading first reported a position in DAWN in Q2 2022 and held it in 8 quarters. The position peaked at $2.38M in Q2 2022. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.
- Simplex Trading reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 64,464 Day One Biopharmaceuticals shares in Q2 2026, an estimated $1.38M.
- Simplex Trading first reported a position in Day One Biopharmaceuticals in Q2 2022 and held it in 8 quarters.
- Simplex Trading's Day One Biopharmaceuticals position peaked at $2.38M in Q2 2022.
- 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.